Manidipina Generis (Manidipine Dihydrochloride)

Manidipine, a dihydropyridine calcium channel blocker, is used to treat conditions related to elevated vascular resistance.

• Hypertension: lowers systolic and diastolic blood pressure in adults with primary hypertension.
• Essential hypertension: provides long‑term blood pressure control to reduce cardiovascular strain.
• High blood pressure: assists in achieving target blood pressure levels as part of antihypertensive therapy.

• Manidipine blocks L‑type calcium channels in vascular smooth muscle, preventing calcium influx that is required for contraction. This inhibition leads to relaxation of arterial smooth muscle, vasodilation, and a decrease in peripheral vascular resistance, thereby lowering systemic blood pressure. The drug exhibits high affinity for arterial over cardiac L‑type channels, producing a pronounced effect on peripheral vessels while minimizing direct cardiac depression. Its antihypertensive effect is dose‑dependent and sustained with once‑daily dosing.

Manidipine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Headache: mild to moderate head pain.
• Flushing: sensation of warmth and redness.
• Peripheral edema: swelling of ankles or feet.
• Dizziness: light‑headed feeling, especially on standing.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure.
• Hepatic dysfunction: elevated liver enzymes or hepatitis.
• Allergic reactions: rash, itching, or anaphylaxis.

When prescribing Manidipine, clinicians should consider several precautionary measures to ensure safe use.

• Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension.
• Cardiovascular disease: use cautiously in patients with severe aortic stenosis or heart failure.
• Liver impairment: dose adjustment may be needed in hepatic dysfunction.
• Concomitant diuretics: monitor electrolytes and renal function.
• Pregnancy and lactation: avoid use as safety has not been established.
• Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Manidipine can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase plasma levels, risk of hypotension.
• Grapefruit juice: can elevate drug concentration, leading to adverse effects.

Moderate Interactions (Monitor Closely)

• Other antihypertensives (e.g., ACE inhibitors, beta‑blockers): may cause additive blood pressure lowering.
• Diuretics: increase risk of electrolyte imbalance and hypotension.
• CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce effectiveness.